| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MDS.21099 |
| P698 | PubMed publication ID | 16986143 |
| P50 | author | Richard W. Walker | Q39034280 |
| P2093 | author name string | Mark A Lee | |
| Anthony J Hildreth | |||
| Wendy M Prentice | |||
| P2860 | cites work | An Inventory for Measuring Depression | Q26778503 |
| A new short form individual quality of life measure (SEIQoL-DW): application in a cohort of individuals with HIV/AIDS. | Q36599136 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| quality of life | Q13100823 | ||
| P304 | page(s) | 1929-1934 | |
| P577 | publication date | 2006-11-01 | |
| P1433 | published in | Movement Disorders | Q1486418 |
| P1476 | title | Individualized assessment of quality of life in idiopathic Parkinson's disease. | |
| P478 | volume | 21 |
| Q38215506 | Apomorphine and levodopa infusion therapies for advanced Parkinson's disease |
| Q37507973 | Apomorphine and levodopa infusion therapies for advanced Parkinson's disease: selection criteria and patient management |
| Q43747340 | Conceptualizing and prioritizing clinical trial outcomes from the perspectives of people with Parkinson's disease versus health care professionals: a concept mapping study. |
| Q48238130 | Effect of subthalamic nuclei electrical stimulation in the treatment of Parkinson's disease |
| Q48747132 | Health-related quality of life among community-dwelling patients with intractable neurological diseases and their caregivers in Japan |
| Q37898591 | Health-related quality-of-life scales in Parkinson's disease: critique and recommendations |
| Q35538809 | Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial |
| Q34544024 | Improved nutritional status is related to improved quality of life in Parkinson's disease |
| Q48056893 | Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories |
| Q48286466 | Measuring outcomes in Parkinson's disease: a multi-perspective concept mapping study. |
| Q37678381 | Oral and infusion levodopa-based strategies for managing motor complications in patients with Parkinson's disease |
| Q38074837 | Palliative care and end-of-life planning in Parkinson's disease. |
| Q38424277 | Psychometric validation of the revised SCOPA-Diary Card: expanding the measurement of non-motor symptoms in Parkinson's disease |
| Q36690356 | Quality of life in people with Parkinson's disease: the relevance of social relationships and communication |
| Q48821235 | Quality of life, caregiver burden and insurance in patients with Parkinson's disease in Germany |
| Q48253584 | Quality of life, health status and caregiver burden in Parkinson's disease: relationship to executive functioning |
| Q42135643 | Social support associated with quality of life in home care patients with intractable neurological disease in Japan |
| Q33629369 | Somatically ill persons' self-nominated quality of life domains: review of the literature and guidelines for future studies |
| Q49064482 | Strategies to maintain quality of life among people with Parkinson's disease: what works? |
| Q39892565 | The experience of using the SEIQoL-DW with patients with advanced chronic obstructive pulmonary disease (COPD): issues of process and outcome |
| Q39296995 | The pragmatic use of apomorphine at the end of life |
| Q37507780 | The use, feasibility and psychometric properties of an individualised quality-of-life instrument: a systematic review of the SEIQoL-DW. |
| Q30240282 | What is quality of life and how do we measure it? Relevance to Parkinson's disease and movement disorders |
Search more.